Perforomist: payments to doctors
Payments that named Perforomist as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $509K
- Providers
- 10,318
- Transactions
- 30,222
- Average per transaction
- $17
The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 10,318 providers the average total is $49, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Mylan Specialty L.p. | $496,002 | 97.5% |
| Mylan Pharmaceuticals Inc. | $11,512 | 2.3% |
| Mylan LLC | $1,148 | 0.2% |
| Mylan Inc. | $19 | 0.0% |